Randomized controlled study of ursodeoxycholic acid (UDCA) with or without bezafibrate in primary biliary cirrhosis
Not Applicable
- Conditions
- Primary biliary cirrhosis
- Registration Number
- JPRN-C000000225
- Lead Sponsor
- Gunma Liver Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
liver diseases with other causes, such as chronic hepatitis B or C, or autoimmune hepatitis Severe renal diseases administration of steroids or glycyrrhizin within three months before entry administration of other fibrates
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ALP, gamma-GTP
- Secondary Outcome Measures
Name Time Method cytokines